French biotech startup Generare has closed a €5 million seed round (around $5.5 million at current exchange rates) to step up development of what it touts as a highly scalable approach to identifying promising compounds for drug discovery that already exist in nature. It’s focused on sifting for molecules that are produced by microorganisms but […]
© 2024 TechCrunch. All rights reserved. For personal use only.
